Clean beauty' in dermatology: a scoping review

Abstract

The emergence of “clean beauty” as a consumer label has become a notable marketing trend, developed in the absence of standardized regulatory definitions, and it has been associated with shifts in consumer behaviors on a global scale. Terms such as “natural,” “organic,” and “cruelty-free” are frequently used without clear definitions, complicating safety assessments and potentially misleading both consumers and clinicians. Although these products are marketed as safer alternatives, emerging evidence challenges this assumption. The exclusion of certain ingredients, such as parabens, has in some cases led to substitution with more allergenic compounds, including isothiazolinones, contributing to rising cases of allergic contact dermatitis.1 Analysis of pediatric-targeted “clean” products reveals the presence of potential allergens such as fragrances and cocamidopropyl betaine, which can exacerbate conditions such as atopic dermatitis in vulnerable populations.2 A critical gap exists between marketing claims and evidence-based dermatological guidance in the clean beauty space, particularly with product labelling and its implications for inflammatory dermatoses. This review addresses the gap by evaluating the current literature to inform clinical decision-making and enhance patient education.